Co-Authors
This is a "connection" page, showing publications co-authored by Gary Lyman and Giuseppe Curigliano.
Connection Strength
0.052
-
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer. Eur J Cancer. 2019 10; 120:1-9.
Score: 0.052
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.